References
- Kiesler C. A., Simpkins C. G., Morton T. L. Prevalence of dual diagnoses of mental and substance abuse disorders in general hospitals. Hosp. Community Psychiatry 1991; 42: 400–403
- Drake R. E., Osher F. C, Wallach M. A. Alcohol use and abuse in schizophrenic prospective community study. J. Nerv. Ment. Dis. 1989; 177: 408–414
- McCarrick A. K., Manderscheid R. W., Bertolucci D. E. Correlates of acting-out behaviors among young adult chronic patients. Hosp. Community Psychiatry 1985; 36: 848–853
- Pristach C. A., Smith C. M. Medication compliance and substance abuse among schizophrenic patients. Hosp. Community Psychiatry 1990; 41: 1345–1348
- Negrete J. C, Knapp W. P., Douglas D. E., et al. Cannabis affects the severity of schizophrenia symptoms: Results of a clinical survey. Psychol. Med. 1986; 16: 515–520
- Sater D. Substance abuse by young adult chronic patients. Hosp. Community Psychiatry 1987; 38: 511–514
- Caton C. The new chronic patient and the system of community care. Hosp. Community Psychiatry 1981; 32: 475–478
- Bowers B. B., Mazure C. M., Nelson J. C, Jatlow P. I. Psychotogenic drug use and neuroleptic response. Schizophr. Bull. 1990; 16: 81–85
- Dixon L., Haas G., Weiden P. J., Sweeney J., Frances A. J. Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. Am. J. Psychiatry 1991; 148: 224–230
- Overall J. E., Gorham D. R. The Brief Psychiatric Rating Scale. Psychol. Rep. 1962; 10: 799–812
- Endicott J., Spitzer R. L. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry 1978; 35: 837–844
- Wyatt R. J., Torgow J. S. A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders. J. Psychiatr. Res. 1976; 13: 91–98
- Tien A. Y., Anthony J. C. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J. Nerv. Ment. Dis. 1990; 178: 473–480
- Andreasson S., Engstom A., Alleback P., et al. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483–1486
- Satel S. L., Southwick S. M., Charney D. S. Features of Cocaine-Induced Paranoia. Presented at the 143rd Annual Meeting of the American Psychiatric Association. 1990. New York, New YorkMay12–17
- Brady K. T., Lydiard R. B., Malcolm R., Ballenger J. C. Cocaine-induced psychosis. Psychiatry 1991; 52: 509–512
- Jones R. T. Pharmacology of cocaine. Cocaine: A Clinician's Handbook, A. Washton, M. S. Gold. Guilford Press, New York 1987; 57–72
- Gawin F., Ellinwood E. H. Cocaine and other stimulants. New Engl. J. Med. 1988; 318: 1173–1182
- Zukin S. R., Javitt D. C. The brain NMDA receptor, psychotomimetic drug effects, and schizophrenia. Rev. Psychiatry 1991; 10: 480–498
- Muller P., Britton R. S., Seeman P. The effects of long-term ethanol on brain receptors for dopamine, acetylcholine, serotonin and noradrenaline. Eur. J. Pharmacol. 1980; 65: 31–37
- Thomas P. K. Alcohol and disease: Central nervous system. Acta. Med. Scand. 1985; 703: S251–S264
- Bernharson G., Gunne L. Forty-six cases of psychosis in cannabis users. Int. J. Addict. 1972; 7: 9–16
- Sherer M. A., Kumor K. M., Cone E. J., Jaffe J. H. Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings. Arch. Gen. Psychiatry 1988; 45: 673–677
- Snyder S. H. Amphetamine psychosis: A “model” schizophrenia mediated by catecholamines. Am. J. Psychiatry 1973; 130: 61–67
- Smith R. C, Strizich M., Klass D. Drug history in tardive dyskinesia. Am. J. Psychiatry 1978; 135: 1402–1403
- Rey J. M., Hunt G. E., Johnson G. F. S. Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale. Aust. N. Z. J. Psychiatry 1981; 15: 33–37
- Yassa R., Nair V., Schwartz G. Tardive dyskinesia and the primary psychiatric diagnosis. Psychosomatics 1984; 25: 135–138
- Olivera A., Kiefer M. W., Manley N. K. Tardive dyskinesia in psychiatric patients with substance use disorders. Am. J. Drug Alcohol Abuse 1990; 16: 57–66
- Dixon L., Weiden P. J., Haas G., Sweeney J., Frances A. J. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Compr. Psychiatry 1992; 33: 121–122
- Kane J. M., Smith J. M. Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979. Arch. Gen. Psychiatry 1982; 39: 473–481
- Bannet J., Belmaker R. N., Ebstein R. P. The effect of drug holidays in an animal model of tardive dyskinesia. Psychopharmacology 1980; 69: 223–224